Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Most Trending
-8.97%
-4.37%
-0.07%
+1.66%
+5.77%
Most Trending
-8.97%
-4.37%
-0.07%
+1.66%
+5.77%
Oracle Corporation is scheduled to release its quarterly results, which are expected to show a sales increase of 17-19%, surpassing the previous quarter's sales of $12.3 billion. Analysts are forecasting sales of $12.43 billion for this quarter. Additionally, the company's earnings per share is expected to increase by 4-7%, ranging between $1.17 and $1.21, while analysts anticipate earnings per share of $1.2.
The increasing prevalence of hybrid work arrangements and the rapid pace of digital transformation are expected to drive up demand for Oracle's cloud offerings. Moreover, Oracle's acquisition of Cerner, which was completed in cash for 28.3 billion dollars at the beginning of last year, is anticipated to bolster the company's presence in the healthcare industry, with Cerner contributing approximately 1.5 billion dollars to Oracle's total sales revenue.
On January 24th, Oracle unveiled additional logistics features for its Fusion Cloud Supply Chain service and introduced enhancements to its manufacturing capabilities. These new offerings aim to enhance global supply chain efficiency.
Oracle has recently secured a number of prominent clients for its Oracle Fusion ERP cloud system, particularly in the banking and healthcare sectors, which could potentially bolster the company's ERP business. Furthermore, the widespread adoption of Oracle's autonomous database service, which employs machine learning and artificial intelligence, may provide additional support for the company's financial performance.
Oracle exceeded analysts' projections in its most recent financial reports, generating $12.3 billion in revenue as opposed to the anticipated $12.05 billion. Additionally, the company's earnings per share (NON-GAAP) came in at $1.21 per share, surpassing the expected $1.18 per share.
Please note that the article should not be considered as investment advice or marketing, and it does not take into account the personal data and requirements of any individual. It is not a substitute for the reader's own judgment, and it should not be considered as advice or recommendation for buying or selling any securities or financial products.
Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future
FIND US ON
Receive our Daily Alerts
Enter your email to receive daily alerts
Leading Gainers
Upgrades
Downgrades
Top Leaders
Ipo's
Dividend
Option Activity
Insiders Activity
Institutional Holdings
New Products
FDA Approvals
Agreements
Financial Reports
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Find out what happening right now and get all the pieces of the puzzle on important data activity before the major news sources break the story and see what are the trends
FIND US ON
Receive our Daily Alerts
Enter your email to receive daily alerts
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
